Weisberg, Edmund M. http://orcid.org/0000-0002-2514-1219
Chu, Linda C. http://orcid.org/0000-0001-9729-2756
Nguyen, Benjamin D.
Tran, Pelu
Fishman, Elliot K. http://orcid.org/0000-0002-2567-1658
Article History
Received: 29 June 2021
Revised: 21 January 2022
Accepted: 28 January 2022
First Online: 15 February 2022
Declarations
:
: Co-authors Weisberg, Chu, and Fishman received funding from the Lustgarten Foundation, and declare no conflicts of interest. Dr. Nguyen is the product manager of Transcarent, and Mr. Tran is the Chief Executive Officer of Ferrum Health, whose product is mentioned in this paper.